All In MedTech

Device Trial Radar · NCT04533503

Vis-Rx Post-Market Evaluation

Post-Market Clinical Evaluation of the Gentuity High-Frequency Optical Coherence Tomography Imaging System and Vis-Rx Micro-Imaging Catheter

Last checked: Nov 19, 2026Latest source record: Mar 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

257

Actual

Start

Feb 22, 2021

Primary completion

Jan 25, 2023

Study completion Jan 25, 2023

Sponsor

Lead sponsor
Gentuity, LLCNot on our public-company list
Sponsor type
Industry
First posted
Aug 31, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Post-market clinical evaluation of the Gentuity High-Frequency Optical Coherence Tomography (HF-OCT) System and the Vis-Rx Micro-Imaging Catheter for use in Percutaneous Coronary Intervention (PCI) procedures.

Conditions

  • Coronary Artery Disease

Interventions

  • HF-OCT Imaging with the Vis-Rx Micro-Imaging CatheterDevice

    Intracoronary HF-OCT imaging of the target lesion(s) during the procedure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical performanceTime frame: Immediately after the procedure
  2. Technical performanceTime frame: Up to 3 months following the procedure

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • University of South Florida

    Tampa, Florida

  • Baptist Health Lexington

    Lexington, Kentucky

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.